In the present study, we evaluated the efficacy of cytokine adjuvant (recombinant mouse GM-CSF and IL-2) vaccine pulsed with inactivated CT26.WT colon tumor cells via measuring the tumor-specific CTL activity and associated anti-tumor effect in a colon cancer model. The gene discussed is IL2; the disease is malignant colon neoplasm.